Clin2
NCT06738225Possibly a fitNot yet recruiting

Blood test for early detection of colorectal cancer

MicroRNAsColorectal CancermiR-15bmiR-21

Part of Cancer, Digestive system clinical trials.

This study looks for certain molecules in your blood that might help detect colorectal cancer earlier. Researchers will compare blood samples from people with colorectal cancer to samples from healthy people to find these markers.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
80 people
Ages
18 years to 75 years
Study type
Observational

Who can take part

  • You are between 18 and 75 years old.
  • You either have colorectal cancer (confirmed by a biopsy) or are a healthy person without colorectal disease.
  • If you have colorectal cancer, you have not yet received chemotherapy or radiation for it.
  • You have not had colorectal cancer before.
  • You do not have cancer that started in another organ and spread to your colon or rectum.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06991452Not yet recruiting
Blood tests for early detection and monitoring of colorectal cancer

This study looks for early signs of colorectal cancer and ways to check if it comes back after treatment. It uses blood samples to find markers that could help doctors diagnose and monitor the disease more effectively.

Shanghai, Shanghai Municipality
NCT07310446Recruiting
Blood test study for colorectal cancer detection

This study is collecting blood samples to improve a test that looks for signs of colorectal cancer in the blood. It may help find cancer earlier or better understand how to detect it.

Lake Barrington, Illinois
NCT07224789Recruiting
Finding colorectal cancer early with a blood test for circular RNA

This study is testing whether a simple blood test can detect circular RNA, a potential early marker for colorectal cancer. If you have early-stage colorectal cancer (stage I–III) and have had a blood sample taken before any treatment, you may be able to help researchers develop a better detection method.

Duarte, California
NCT07068529Recruiting
Metabolic biomarkers for early diagnosis and recurrence of colorectal cancer

This study looks at metabolic biomarkers in blood and tumor tissue to help detect colorectal cancer earlier, predict outcomes, and monitor for recurrence. It includes both people newly diagnosed with colorectal cancer and healthy volunteers for comparison.

Shanghai, Shanghai Municipality
NCT06889844Recruiting
Blood test for colorectal cancer cross-reactivity study

This research study uses a blood test to look for signs of colorectal cancer in people who have other types of cancer or digestive diseases. The goal is to see if the test can correctly tell the difference between colorectal cancer and other conditions.

Málaga, Andalusia
NCT07649057Recruiting
Urine Test for Early Colorectal Cancer Detection

This study tests whether a simple urine sample can detect colorectal cancer or precancerous polyps. Researchers want to see if this non-invasive test could help identify people at risk before symptoms develop or catch cancer earlier.

New York, New York

Hear when a new Colorectal cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.